Skip to content

Daily Disposable Toric Comparative Trial in Europe

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01070381
Enrollment
220
Registered
2010-02-18
Start date
2010-01-31
Completion date
2010-03-31
Last updated
2013-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Astigmatism

Brief summary

The purpose of this study is to investigate the subjective and objective performance of two daily disposable lenses for wearers with astigmatism.

Interventions

Commercially marketed, toric, soft contact lens for daily disposable wear

DEVICEocufilcon D contact lens

Commercially marketed, toric, soft contact lens for daily disposable wear

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Current soft contact lens wearers able to be fit with soft toric lenses in the protocol-specified parameters. * Achieve 0.5 or better distance visual acuity in each eye at time of dispense. * Achieve acceptable or optimal fit in each eye at time of dispense. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Habitual daily disposable contact lens wearer. * Sleeps in contact lenses overnight. * Currently enrolled in an ophthalmic clinical trial. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Overall Comfort1 week of wearOverall Comfort, as interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall comfort is measured on a 10-point scale, with 1 being poor and 10 being excellent.

Participant flow

Pre-assignment details

Three participants were enrolled but not dispensed due to failing inclusion/exclusion criteria. These participants were included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participants by arm

ArmCount
Overall Study
This reporting group includes all enrolled and dispensed subjects
217
Total217

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 2, 1 Week of WearHandling01
Period 2, 1 Week of WearUnacceptable Vision10

Baseline characteristics

CharacteristicOverall Study
Age, Continuous33.2 years
STANDARD_DEVIATION 9.4
Sex: Female, Male
Female
151 Participants
Sex: Female, Male
Male
66 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
16 / 21727 / 216
serious
Total, serious adverse events
0 / 2170 / 216

Outcome results

Primary

Overall Comfort

Overall Comfort, as interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall comfort is measured on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: 1 week of wear

Population: Analysis conducted per protocol, with exclusions due to reasons such as, major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon AOverall Comfort7.6 Units on a ScaleStandard Deviation 1.9
Ocufilcon DOverall Comfort7.6 Units on a ScaleStandard Deviation 1.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026